Alphabet Inc. (ETR:ABEC)

Achilles Therapeutics Revenue

Alphabet had revenue of $96.43B USD in the quarter ending June 30, 2025, with 13.79% growth. This brings the company's revenue in the last twelve months to $371.40B, up 13.13% year-over-year. In the year 2024, Alphabet had annual revenue of $350.02B with 13.87% growth.

• Revenue (ttm): $371.40B
• Revenue Growth: +13.13%
• P/S Ratio: 6.44
• Revenue / Employee: $2.03M
• Employees: 183,323
• Market Cap: 2,036.49B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	350.02B	42.62B	13.87%
Dec 31, 2023	307.39B	24.56B	8.68%
Dec 31, 2022	282.84B	25.20B	9.78%
Dec 31, 2021	257.64B	75.11B	41.15%
Dec 31, 2020	182.53B	20.67B	12.77%